Stay updated on Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial
Sign up to get notified when there's something new on the Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial page.
Latest updates to the Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial page
- CheckyesterdayChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.3%
- Check8 days agoNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements in the latest release.SummaryDifference0.3%
- Check44 days agoChange DetectedThe website has been updated to version 2.10.0, introducing new features for viewing and comparing study record versions.SummaryDifference6%
- Check51 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.3%
- Check65 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content or details of the webpage.SummaryDifference0.3%
- Check70 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.SummaryDifference0.3%
Stay in the know with updates to Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial page.